Patent Assignment
Reel/Frame 075545/0601
Release of Security Interest
Recorded: 2026-05-05
Received: 2026-05-05
Pages: 14
Assignor
OXFORD FINANCE LLC
Executed: 2026-05-04
Assignees
LEXICON PHARMACEUTICALS, INC.
2445 TECHNOLOGY FOREST BLVD., 11TH FLOOR, THE WOODLANDS, TX, 77381, UNITED STATES
LEXICON PHARMACEUTICALS
2445 TECHNOLOGY FOREST BLVD., 11TH FLOOR, THE WOODLANDS, TX, 77381, UNITED STATES
Covered Properties
(67)
Compounds and Methods for Treating Chemotherapy-Induced Pain
Application:
19/053,009 →
Compounds and Methods of Their Use
Application:
19/052,650 →
Compounds and Methods for Treating Spasticity
Application:
18/133,926 →
Methods and Compounds Useful in the Synthesis of an AAK1 Inhibitor
Application:
18/114,050 →
Solid Forms of (S)-1-((2',6-Bis(Difluoromethyl)-[2,4'-Bipyridin]-5-Yl)Oxy)-2,4-Dimethylpentan-2-Amine and Salts Thereof
Application:
18/114,104 →
Process for Preparing the Crystalline Form Ii of Sotagliflozin
Application:
17/631,209 →
Continuous Process for Preparing the Crystalline Form Ii of Sotagliflozin
Application:
17/631,191 →
Compounds and Methods for Treating or Preventing Cardiovascular Diseases and Conditions
Application:
17/574,977 →
Pyrazolo[1,5]Pyrimidine-Based Compounds and Methods of Their Use to Treat Viral Infections
Application:
17/234,349 →
Compounds and Methods for Treating Viral Infections
Application:
17/233,830 →
Use of Sotagliflozin for the Treatment of Patients with Type 1 Diabetes Mellitus
Application:
16/804,255 →
Compositions Comprising and Methods of Using Inhibitors of Sodium-Glucose Cotransporters 1 and 2
Application:
16/792,803 →
Antibodies That Bind Notum Pectinacetylesterase
Application:
16/277,466 →
Inhibitors of Sodium Glucose Transporter 1 for Constipation
Application:
15/601,175 →
PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
Application:
15/145,435 →
Inhibitors of Sodium Glucose Cotransporter 1
Application:
14/943,505 →
Inhibitors of Adapter Associated Kinase 1, Compositions Comprising Them, and Methods of Their Use
Application:
14/658,653 →
PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
Application:
14/483,898 →
4H-Thieno[3,2-C]Chromene-Based Inhibitors of Notum Pectinacetylesterase and Methods of Their Use
Application:
14/284,106 →
Inhibitors of Sodium Glucose Cotransporter 1
Application:
14/082,786 →
Sodium Glucose Co-Transporter Inhibitors and Methods of Their Use
Application:
13/925,981 →
Pyrazolo[1,5-A]Pyrimidine-Based Compounds, Compositions Comprising Them, and Methods of Their Use
Application:
13/785,355 →
Imidazo[1,2-B]Pyridazine-Based Compounds, Compositions Comprising Them, and Methods of Their Use
Application:
13/785,271 →
Methods of Treating Diabetes
Application:
13/530,645 →
LIMK2 Inhibitors, Compositions Comprising Them, and Methods of Their Use
Application:
13/486,122 →
MST1 Kinase Inhibitors and Methods of Their Use
Application:
13/410,407 →
Methods of Treating Ulcerative Colitis
Application:
13/343,073 →
Monoclonal Antibodies Against ANGPTL4
Application:
13/315,027 →
Solid Forms of 3-(4-(Aminomethyl)-1-(5-Methyl-7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)Piperidine-4-Carboxamido)Phenyl Dimethylcarbamate
Application:
13/288,321 →
Methods and Compounds Useful for the Preparation of Sodium Glucose Co-Transporter 2 Inhibitors
Application:
13/207,576 →
Monoclonal Antibodies Against ANGPTL3
Application:
13/073,617 →
Modulators of G Protein-Coupled Receptor 88
Application:
12/898,016 →
Modulators of G Protein-Coupled Receptor 88
Application:
12/897,004 →
Modulators of G Protein-Coupled Receptor 88
Application:
12/895,916 →
Sulfanyl-Tetrahydropyran-Based Compounds and Methods of Their Use
Application:
12/858,666 →
Multicyclic Compounds and Methods of Their Use
Application:
12/633,453 →
Monoclonal Antibodies Against ANGPTL4
Application:
12/631,598 →
Methods of Treating Rheumatoid Arthritis
Application:
12/628,309 →
Heterocyclic Compounds, Compositions Comprising Them and Methods of Their Use
Application:
12/545,954 →
(E)-1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-Imidazol-2-Yl)Ethanone Oxime Dihydrate and Methods of Its Use
Application:
12/536,714 →
Solid Forms of (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-Ethoxybenzyl)Phenyl)-6-(Methylthio)Tetrahydro-2H-Pyran-3,4,5-Triol and Methods of Their Use
Application:
12/503,225 →
Solid Forms of (1R,2S,3R)-1-(2-(Isoxazol-3-Yl)-1H-Imidazol-4-Yl)Butane-1,2,3,4-Tetraol and Methods of Their Use
Application:
12/485,444 →
Methods of Preparing Imidazole-Based Bicyclic Compounds
Application:
12/485,507 →
LIMK2 Inhibitors, Compositions Comprising Them, and Methods of Their Use
Application:
12/426,661 →
Compositions and Methods for Treating Immunological and Inflammatory Diseases and Disorders
Application:
12/204,918 →
Substituted Pyrrolo[2,3-D]Pyrimidines as Lim Kinase 2 Inhibitors
Application:
12/188,515 →
Methods and Compounds Useful for the Preparation of Sodium Glucose Co-Transporter 2 Inhibitors
Application:
12/174,722 →
Methods of Using and Compositions Comprising Tryptophan Hydroxylase Inhibitors
Application:
12/144,953 →
Methods of Preparing Imidazole-Based Compounds
Application:
12/101,410 →
Piperdine-Based Inhibitors of Sodium Glucose Co-Transporter 2 and Methods of Their Use
Application:
12/041,860 →
Heterocyclic Compounds, Compositions Comprising Them and Methods of Their Use
Application:
12/038,872 →
4-Amino-1H-Pyrimidin-2-One Based Compounds, Compositions Comprising Them and Methods of Their Use
Application:
11/954,421 →
O-Linked Pyrimidin-4-Amine-Based Compounds, Compositions Comprising Them, and Methods of Their Use to Treat Cancer
Application:
11/954,433 →
Monoclonal Antibodies Against ANGPTL3
Application:
12/001,012 →
Inhibitors of Sodium Glucose Co-Transporter 2 and Methods of Their Use
Application:
11/862,690 →
Synthesis of Piperazines, Piperidines and Related Compounds
Application:
11/832,738 →
Imidazole-Based Compounds, Compositions Comprising Them and Methods of Their Use
Application:
11/698,253 →
Aryl Pyridines and Methods of Their Use
Application:
11/497,539 →
4-Piperidin-1-Yl-7H-Pyrrolo[2,3-D]Pyrimidine Compounds
Application:
11/354,636 →
Knockout Animals Manifesting Hyperlipidemia
Application:
11/347,838 →
Monoclonal Antibodies Against ANGPTL4
Application:
11/327,844 →
Novel Thiazolopyrazoles and Methods of Their Use
Application:
11/094,241 →
Novel Human Kinases and Polynucleotides Encoding the Same, and Uses Thereof
Application:
11/025,671 →
Novel Human Kinases and Polynucleotides Encoding the Same
Application:
10/803,278 →
Novel Human Hydroxylases and Polynucleotides Encoding the Same
Application:
10/154,674 →
Novel Human Kinases and Polynucleotides Encoding the Same
Application:
10/196,927 →
Novel Human Kinases and Polynucleotides Encoding the Same, and Uses Thereof
Application:
10/010,720 →